|The ADAM9 adam9 (Catalog #MBS9226889) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.
The ADAM9 adam9 product has the following accession number(s) (GI #24211441) (NCBI Accession #Q13443.1) (Uniprot Accession #Q13443). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Probable zinc protease. May mediate cell-cell or cell- matrix interactions. Isoform 2 displays alpha-secretase activity for APP.
Cellular Location: Isoform 1: Cell membrane; Single-pass type I membrane protein. Tissue Location: Widely expressed. Expressed in chondrocytes. Isoform 2 is highly expressed in liver and heart. The following patways have been known to be associated with this gene. Breast Neoplasms, Carcinoma, Hepatocellular, Cardiovascular Diseases, Inflammation, Liver Diseases, Liver Neoplasms, Necrosis, Neoplasm Metastasis, Neoplasms, Experimental, Prostatic Neoplasms are some of the diseases may be linked to ADAM9 Antibody (C-term) Blocking Peptide. Blood, Bone, Brain, Heart, Kidney, Liver, Lung, Muscle, Prostate, Vascular tissues are correlated with this protein. ADAM9 also interacts with the following gene(s): MAD2L2, REG4, SH3GL2, SNX9, TNF.